Biochemical, pharmacological, and phase I clinical evaluation of pseudoisocytidine. | Cancer Res;40(11): 4243-9, 1980 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Biochemical, pharmacological, and phase I clinical evaluation of pseudoisocytidine.

Woodcock, T M; Chou, T C; Tan, C T; Sternberg, S S; Philips, F S; Young, C W; Burchenal, J H.

Cancer Res ; 40(11): 4243-9, 1980 Nov.

Article in En | MEDLINE | ID: mdl-7471064

Subject(s)

Antineoplastic Agents; Cytidine/therapeutic use; Cells, Cultured; Cytidine/adverse effects; Cytidine/metabolism; Drug Evaluation; Humans; Kinetics; Leukemia/metabolism; Liver/drug effects; Metabolic Clearance Rate

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Cytidine / Antineoplastic Agents Type of study: Clinical_trials Limits: Humans Language: En Journal: Cancer Res Year: 1980 Document type: Article Country of publication: United States

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Cytidine / Antineoplastic Agents Type of study: Clinical_trials Limits: Humans Language: En Journal: Cancer Res Year: 1980 Document type: Article Country of publication: United States